Yahoo Web Search

Sign In

Search results

  1. www.sobi.comSobi - Transforming the lives of people with rare diseases

    4 days ago · At Sobi, we are dedicated to transforming the lives of people with rare and debilitating diseases. Meet some of the people who inspire us. Their real-life experiences and stories reinforce our commitment to patients. Read the stories.

    • About

      About us Sobi is a specialised international...

    • Disease areas

      Summary of Sobi’s therapeutic areas – haematology and...

    • Key medicines

      Alprolix ® * (eftrenonacog alfa). Alprolix ® (eftrenonacog...

    • Stories

      Patients and science lie at the heart of everything we do....

    • Sustainability

      Sobi's main contribution to the global sustainable...

    • Careers

      At Sobi, we are transforming the lives of people living with...

  2. Images

    • Swedish Orphan Biovitrum AB (SOBI) Dividends
    • Swedish Orphan Biovitrum - Crunchbase Company Profile & Funding
    • ORFADIN (Swedish Orphan Biovitrum AB (publ)): FDA Package Insert
    • Swedish Orphan Biovitrum Zaditen Ögondroppar 0,4ml 20 Doser - Hitta ...

    View all

  3. en.wikipedia.org › wiki › Swedish_Orphan_BiovitrumSwedish Orphan Biovitrum - Wikipedia

    Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees.

  4. www.sobi.com › en › pipelinePipeline | Sobi

    Sobi’s R&D pipeline: colour-coded chart showing haematology, immunology, and specialty care treatments in phases 1, 2 and 3 and at the registration stage.

  5. Videos

    View all

  6. www.bloomberg.com › quote › SOBI:SSSOBI: Swedish Orphan Biovitrum AB Stock Price Quote - Bloomberg

    Jun 28, 2024 · Stock analysis for Swedish Orphan Biovitrum AB (SOBI:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

    • 1.8K

  7. www.linkedin.com › company › sobiSobi - Swedish Orphan Biovitrum AB (publ) | LinkedIn

    Sobi is a biopharmaceutical company specialising in rare diseases, with a global presence and a listed share. Follow Sobi on LinkedIn to get updates on its products, events, sustainability, and career opportunities.

  8. finance.yahoo.com › quote › BIOVFSwedish Orphan Biovitrum AB (publ) (BIOVF) - Yahoo Finance

    Find the latest Swedish Orphan Biovitrum AB (publ) (BIOVF) stock quote, history, news and other vital information to help you with your stock trading and investing.

  9. www.bloomberg.com › news › articlesAdvent, GIC Bid $8 Billion for Swedish Orphan-Drug Maker Sobi

    Sep 2, 2021 · Private equity firm Advent International and Singapore wealth fund GIC agreed to buy drugmaker Swedish Orphan Biovitrum AB for 69 billion kronor ($8 billion) in the largest buyout of a Nordic...